 Home > Active Ingredient News > Immunology News > Eur J Rheumatol: secukinumab treatment has no adverse effect on the patient's hematological parameters

Eur J Rheumatol: secukinumab treatment has no adverse effect on the patient's hematological parameters

 Last Update: 2021-05-20
 Source: Internet
 Author: User

Tags

protein rate

folic acid target

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Sekkizumab is a new therapeutic agent for the treatment of ankylosing spondylitis (AS), psoriatic arthritis (PsA) and psoriasis.

The researchers included data on 36 patients (16 males and 20 females) who received secukinumab treatment, and recorded the patients’ age, gender, complete blood count (CBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), uric acid, aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, creatinine value and other drug treatment data.

The average age of the patients was 39.

diagnosis

In summary, these results indicate that secukinumab treatment has no adverse effects on the patient's hematological parameters.

Original source:

Ahmet Karataş, et al.

ncbi.
nlm.
nih.
gov/32910771/" target="_blank" rel="noopener">The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

imiquimod CAS 99011-02-6

CAS No.: 99011-02-6

Pharmacy Grade

$88-98/KG FOB

GMP Factory Supply Isoprinosine CAS 36703-88-5 99% Powder Evergreen EGC-Isoprinosine Powder

CAS No.: 36703-88-5

Pharmacy Grade

$20-22/KG FOB

inosine pranobex bulk Methisoprinol/Isoprinosine 98% Inosine pranobex powder Inosine pranobex

CAS No.: 36703-88-5

$2-2.2/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.